Product Information

DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Leading Pharma, LLC, priced at $0.8314 per ML under NDC 69315030410. Its NADAC has been published 329 times since May 6, 2020.

FDA first approved this application on Jan 24, 2019. Its Orange Book therapeutic-equivalence code is AT.

DORZOLAMIDE HCL 2% EYE DROPS

Dorzolamide hydrochloride
$0.8314per ML

Strength

20 mg/mL

NDC

69315030410

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

DORZOLAMIDE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205294

FDA Approved

1/24/2019

TE Code

AT

On Market Since

12/1/2019

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 329 times since May 6, 2020, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8314 per ML
All-time high$1.8762 (May 13, 2020)
All-time low$0.8212 (Jul 22, 2026)
52-week high$1.0745
52-week low$0.8212
Median price$1.3375
Average price$1.3233
Largest weekly change+42.1% (Sep 18, 2024)
Weeks tracked329
Tracking sinceMay 6, 2020

Price History

1W

+1.2%

1M

+1.2%

3M

-2.8%

6M

-9.0%

1Y

-22.6%

3Y

-38.3%

5Y

-42.1%

All

-55.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Leading Pharma, LLC, is $0.8314 per ML (NDC 69315030410), effective Aug 19, 2026.

How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 55.7%. It has been tracked across 329 weekly CMS publications since May 6, 2020.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?

Since May 6, 2020, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8212 (Jul 22, 2026) to a high of $1.8762 (May 13, 2020), with a median of $1.3375 per ML.

Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?

No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE HCL 2% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?

DORZOLAMIDE HCL 2% EYE DROPS (NDC 69315030410) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.